These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 209902)

  • 1. Tumor cell killing by macrophages activated in vitro with lymphocyte mediators. III. Inhibition by cytochalasins, colchicine, and vinblastine.
    Sharma SD; Piessens WF
    Cell Immunol; 1978 Jul; 38(2):276-85. PubMed ID: 209902
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor cell killing by macrophages activated in vitro with lymphocyte mediators. II. Inhibition by inhibitors of protein synthesis.
    Sharma SD; Piessens WF
    Cell Immunol; 1978 Jul; 38(2):264-75. PubMed ID: 209901
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased binding of tumor cells by macrophages activated in vitro with lymphocyte mediators.
    Piessens WF
    Cell Immunol; 1978 Feb; 35(2):303-17. PubMed ID: 202405
    [No Abstract]   [Full Text] [Related]  

  • 4. The inhibitory effects of colchicine, vinblastine and cytochalasin D on lymphocyte blastogenic responses.
    Tajima M; Fujinaga T; Otomo K; Koike T
    Nihon Juigaku Zasshi; 1989 Apr; 51(2):403-7. PubMed ID: 2739216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of macrophage Fc receptor function by cytochalasin-sensitive structures.
    Atkinson JP; Parker CW
    Cell Immunol; 1977 Oct; 33(2):353-63. PubMed ID: 912763
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of macrophage C3b receptor function by cytochalasin-sensitive structures.
    Atkinson JP; Michael JM; Chaplin H; Parker CW
    J Immunol; 1977 Apr; 118(4):1292-9. PubMed ID: 557509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrogation of tumor rejection by trypan blue.
    Kreider JW; Bartlett GL; DeFreitas E
    Cancer Res; 1978 Apr; 38(4):1036-40. PubMed ID: 205342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation of cytochalasin D and anti-microtubular agents in stimulating superoxide anion production in polymorphonuclear leukocytes.
    Okamura N; Hanakura K; Kodakari M; Ishibashi S
    J Biochem; 1980 Jul; 88(1):139-44. PubMed ID: 6251033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-dependent cytotoxicity: modulation by the cytochalasins and microtubule-disruptive agents.
    Gelfand EW; Morris SA; Resch K
    J Immunol; 1975 Mar; 114(3):919-24. PubMed ID: 1112985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro killing of tumor cells by soluble products of activated guinea pig peritoneal macrophages.
    Sharma SD; Piessens WF; Middlebrook G
    Cell Immunol; 1980 Feb; 49(2):379-83. PubMed ID: 6243515
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of colchicine, vinblastine and cytochalasins on the corticotropic responsiveness and ultrastructure of inner zone adrenocortical tissue in the Pekin duck.
    Cronshaw J; Holmes WN; West RD
    Cell Tissue Res; 1984; 236(2):333-8. PubMed ID: 6329517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the cytoskeleton in secretory processes: lacrimal and salivary glands.
    Rossignol B; Chambaut-Guérin AM; Muller P
    Methods Enzymol; 1983; 98():175-82. PubMed ID: 6686858
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of cytochalasin and alkaloid drugs on the biological expression of herpes simplex virus type 2 DNA.
    Farber FE; Eberle R
    Exp Cell Res; 1976 Nov; 103(1):15-22. PubMed ID: 186287
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of cytoskeleton in natural cell-mediated cytotoxicity against Trichomonas vaginalis.
    Martinotti MG; Gallione MA; Martinetto P; Landolfo S
    Microbiologica; 1982 Oct; 5(4):389-91. PubMed ID: 6296638
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological aspects of hepatocellular carcinoma in the guinea-pig.
    Desai HN
    S Afr Med J; 1976 Oct; 50(46):1863-6. PubMed ID: 63151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased binding and killing of neuraminidase-galactose oxidase-treated tumor cells by normal macrophages.
    Piessens WF
    J Immunol; 1977 Jul; 119(1):167-72. PubMed ID: 194981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of anchorage-modulating doses of concanavalin A, microtubule-disrupting drugs and microfilament perturbants, cytochalasins, on the phosphatidylinositol response of rat lymph-node cells.
    Sasaki T; Hasegawa-Sasaki H
    Biochim Biophys Acta; 1981 Dec; 649(2):449-54. PubMed ID: 7317409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological evidence for the translocation of lysosomal organelles from cytotoxic macrophages into the cytoplasm of tumor target cells.
    Bucana C; Hoyer LC; Hobbs B; Breesman S; McDaniel M; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4444-58. PubMed ID: 187323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked stimulation of lymphocyte-mediated attack on tumor cells by target-directed liposomes containing immune RNA.
    Magee WE; Cronenberger JH; Thor DE
    Cancer Res; 1978 Apr; 38(4):1173-6. PubMed ID: 205346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of cytoskeletal agents on hemispheric functional expression of cell membrane receptors in Xenopus oocytes.
    Matus-Leibovitch N; Gershengorn MC; Oron Y
    Cell Mol Neurobiol; 1993 Dec; 13(6):625-37. PubMed ID: 8194080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.